Back

Eip74EF is a dominant modifier for ALS-FTD linked mutant VCP phenotypes in Drosophila, but not miR-34

Chalmers, M. R.; Kim, J.; Kim, N. C.

2020-11-22 pathology
10.1101/2020.11.20.375360 bioRxiv
Show abstract

In 2012 Liu et al. reported that miR-34 is an age-related miRNA regulating age-associated events and long-term brain integrity in Drosophila. They demonstrated that modulating miR-34 and its downstream target Eip74EF showed beneficial effects on age-related diseases using a Drosophila model of SCA3trQ78. These results imply that miR-34 could be a general genetic modifier and therapeutic candidate for age-related diseases. Therefore, we examined the effect of miR-34 and Eip74EF on another age-related Drosophila disease model. Using a Drosophila model expressing mutant Drosophila VCP that causes amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), or multisystem proteinopathy (MSP), we demonstrated that abnormal eye phenotypes generated by Drosophila VCP R152H were rescued when expressed with Eip74EF siRNA. Contrary to our expectation, miR-34 overexpression resulted in lethality when expressed with mutant VCP. Our data indicate that the other downstream targets of miR-34 might more significantly interact with mutant VCP, causing lethality. Identifying transcriptional targets of Eip74EF might provide valuable insights into diseases caused by mutations in VCP such as ALS, FTD, and MSP.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
25 papers in training set
Top 0.1%
10.6%
2
Frontiers in Aging Neuroscience
67 papers in training set
Top 0.3%
10.2%
3
Cells
232 papers in training set
Top 0.1%
6.9%
4
International Journal of Molecular Sciences
453 papers in training set
Top 1%
4.7%
5
Aging
69 papers in training set
Top 0.6%
4.0%
6
PLOS ONE
4510 papers in training set
Top 36%
4.0%
7
Scientific Reports
3102 papers in training set
Top 30%
4.0%
8
Disease Models & Mechanisms
119 papers in training set
Top 0.3%
4.0%
9
Human Molecular Genetics
130 papers in training set
Top 0.7%
3.7%
50% of probability mass above
10
Frontiers in Genetics
197 papers in training set
Top 2%
3.6%
11
Aging Cell
144 papers in training set
Top 1%
3.6%
12
National Science Review
22 papers in training set
Top 0.6%
2.5%
13
Gene
41 papers in training set
Top 0.9%
1.7%
14
iScience
1063 papers in training set
Top 14%
1.7%
15
BMC Genomics
328 papers in training set
Top 2%
1.7%
16
Heliyon
146 papers in training set
Top 3%
1.4%
17
Frontiers in Molecular Biosciences
100 papers in training set
Top 2%
1.4%
18
Neurobiology of Aging
95 papers in training set
Top 2%
1.4%
19
Molecular Therapy
71 papers in training set
Top 2%
1.2%
20
GeroScience
97 papers in training set
Top 1%
1.2%
21
FASEB BioAdvances
15 papers in training set
Top 0.2%
0.8%
22
Bioscience Reports
25 papers in training set
Top 1%
0.7%
23
Science Bulletin
22 papers in training set
Top 0.9%
0.7%
24
The American Journal of Pathology
31 papers in training set
Top 0.5%
0.7%
25
Genomics, Proteomics & Bioinformatics
171 papers in training set
Top 7%
0.7%
26
Acta Neuropathologica Communications
81 papers in training set
Top 1%
0.7%
27
International Immunopharmacology
15 papers in training set
Top 0.6%
0.7%
28
Journal of Biological Chemistry
641 papers in training set
Top 5%
0.7%
29
Genes
126 papers in training set
Top 4%
0.5%
30
PLOS Pathogens
721 papers in training set
Top 10%
0.5%